Turning great ideas into healthier communities

Focus Area

Communicable Disease Prevention

Click to download the brochure

From sexually transmitted infections to outbreaks of Ebola, Zika and other viruses, communicable diseases are a major threat to the public’s health.

In the U.S. and around the world, PHI develops effective and culturally competent prevention strategies, increases the use of appropriate treatments, and speeds the development and adoption of new technologies to control disease transmission.

We apply our expertise in research, evaluation, capacity building and technological innovation to combat the spread of communicable disease in the U.S. and around the world.

 
And we advocate for proven policies that halt the spread of communicable diseases.

Download PHI's Work in Communicable Disease Prevention: Examples of Impact

 

 


Programs

CAMI Health / The Initiative for Multipurpose Prevention Technologies

As Secretariat of the Initiative for Multipurpose Prevention Technologies (IMPT), CAMI Health leads a global, product neutral collaboration that advances the development of Multipurpose Prevention Technologies (MPTs), an innovative class of products that deliver varied combinations of HIV prevention, other STI prevention, and contraception. MPTs promise to improve the lives of women and their families worldwide.

In this role, CAMI Health serves as the central body that researchers, product developers, funders, policymakers, and advocates rely on for objective technical guidance and strategic planning related to MPTs. By facilitating interdisciplinary partnerships, CAMI Health enables experts from across the family planning, HIV, and STI fields to strategize around the unique technological, market access, and regulatory challenges presented by combined prevention product development, thus refining the pathway to impactful MPT development. 

Support MPTs on the International Day of Action for Women's Health from CAMI Health on Vimeo.

Learn about CAMI Health / The Initiative for Multipurpose Prevention Technologies projects

Global Youth Coalition on HIV/AIDS (GYCA)

The Global Youth Coalition on HIV/AIDS (GYCA) was a youth-led global network of over 800 young people and adult allies working on youth and HIV/AIDS in over 170 countries worldwide. GYCA's mission was to empower young leaders with the skills, knowledge, resources and opportunities they need to scale up HIV/AIDS interventions amongst their peers.

GYCA closed on July 31, 2016. To learn more about the closure, read the Closing Letter. GYCA's most recent tools, resources, and publications are available on its website until January 2017. After January 2017, they will remain available here.

Learn about Global Youth Coalition on HIV/AIDS (GYCA) projects

GOJoven

GOJoven is a multi-year youth development fellowship program focused on building the capacity of young leaders and their organizations in Mesoamerica to improve adolescent sexual and reproductive health outcomes through reducing adolescent pregnancy, maternal mortality, and HIV/STI rates and strengthen the enabling environment to sustain this progress.

Learn about GOJoven projects

Health Intervention Projects for Underserved Populations

Health Intervention Projects for Underserved Populations (HIPUP) aims to improve substance abuse and HIV/AIDS prevention and treatment research and services for underserved populations, such as transgender persons, Asian and Pacific Islander men who have sex with men (MSM) and substance users. Through collaboration with targeted community members, community-based organizations and public health departments, HIPUP, led by Dr. Tooru Nemoto, strives to have a significant impact on health promotion and human rights for underserved communities locally and internationally.

Learn about Health Intervention Projects for Underserved Populations projects

India Antimicrobial Resistance Detection, Prevention and Control Program

The rise of antimicrobial resistance (AMR) is considered a global patient safety issue and a major public health concern. Compounding the threat of AMR, hospital acquired infections further contribute to adverse patient outcomes, and in many instances are caused by highly resistant organisms.

Effective systems, policies, and procedures to accurately detect, monitor, and prevent AMR and hospital acquired infections are essential. These systems include robust laboratory-based surveillance of priority pathogens, effective infection prevention and control practices, strong antimicrobial stewardship, and facility-based surveillance of hospital acquired infections.

Building the capacity to implement and sustain these systems and practices is thus critical to effectively respond to the public health threats posed by AMR. In Tamil Nadu, PHI is working with the CDC and the Government of Tamil Nadu to implement activities in three priority areas:

  1. Antimicrobial Stewardship
  2. Infection Prevention and Control
  3. Laboratory based-surveillance

Learn about India Antimicrobial Resistance Detection, Prevention and Control Program projects

Additional PHI Projects